FirstLook Test

Thank you James Solava, DO, FACP for sharing your experience using FirstLook Lung in your practice. #LungCancerAwarenessMonth #DELFIdiagnostics #EarlyDetectionSavesLives DELFI Diagnostics

Did You Know? Not everyone is eligible for lung cancer screening. Eligibility is based on age and smoking history. Your conversation with your patient may make all the difference in helping them determine whether they're at elevated risk for lung cancer and are eligible for screening. The FirstLook Lung test offers a convenient, accessible, and reliable approach to enhance lung cancer screening with a simple blood test for screen-eligible individuals. Follow FirstLook to learn more about #lungcancer screening, as we post more screening insights throughout Lung Cancer Awareness Month. Find out more about the FirstLook Lung blood test at: https://lnkd.in/ey4HygVW #EarlyDetectionSavesLives #LCAM #LungCancerScreening #lungcancerrisk #DELFI #LungCancerAwarenessMonth #FirstLook DELFI Diagnostics

In DELFI Diagnostics's inaugural blog post, Terri Ann DiJulio, a 3-time survivor of lung cancer, recounts her journey of surviving and thriving. Her story reflects the importance of early detection and intervention and the impact of proactive screening and referrals in primary care. To see how early diagnosis made a difference, read her story: https://bit.ly/3ObvUId #survivor #lungcancer #blogpost #lungcancerscreening #earlydetection #earlydetectionsaveslives #DELFI

#DidYouKnow? Lung cancer is sadly the leading cause of cancer-related deaths for US veterans. A report from #CDMRP found that rates of smoking are as high as 38% for service members compared to 14% for civilians. Many veterans may be eligible for lung cancer screening but could be unaware of the benefits or could have declined it without knowing how vital it is to get annual testing. The DELFI Diagnostics team is committed to raising awareness of the critical importance of early screening in detecting #lungcancer. We honor our service members on Veterans Day by encouraging eligible individuals to prioritize their health and contact their local Lung Precision Oncology Program (LPOP) site to get screened. Take advantage of lung cancer screening to support #earlydetection and #earlytreatment, which can lead to better health outcomes – spread the word to your family and friends! #LungCancerAwarenessMonth #FirstLookLung #DELFI #VeteransDay #LungCancerScreening #Veterans #LPOP #LCAM

Today is National Lung Cancer Screening Day! Here's a reality you know all too well as a clinician: By the time symptoms appear, lung cancer has often already progressed. But together, we can write a different story. The #FirstLook Lung Team at DELFI aims to raise awareness about the importance of #lungcancer screening in early detection and treatment. Our innovative, accessible test is based on a simple blood draw, which can be done during a routine doctor visit. FirstLook is a convenient way to help more screen-eligible patients get the early screening they need. Spread the word on #lungcancerscreening today and throughout Lung Cancer Awareness Month. To learn more about National Lung Cancer Screening Day visit: https://lnkd.in/eFhKnwF5 To learn more about the FirstLook Lung test visit: https://lnkd.in/eCY34wXk #FirstLookLung #DELFI #LungCancerAwarenessMonth #LCAM #NationalLungCancerScreeningDay

As a primary care provider, you're on the frontlines of early detection. This Lung Cancer Awareness Month, let's explore how increasing education to eligible patients can help increase screening adherence. Did you know? When detected early, the 5-year survival rate for lung cancer increases dramatically - from 7% at late stages to nearly 50% when caught early. At DELFI Diagnostics, we're committed to developing screening innovations like #FirstLook Lung to help encourage more patients to know that early detection starts with getting tested. Join our community of healthcare professionals following #FirstLook Lung this November as we share insights on improving lung cancer screening rates in primary care settings. #LungCancerAwarenessMonth #PrimaryCare #EarlyDetectionSavesLives #LCAM #LungCancerScreening #DELFI

#FirstLook Lung is a blood-based test from DELFI Diagnostics, which offers a convenient, personalized approach to enhance #lungcancer screening. Once results are received, providers and patients can discuss them together, and providers can recommend the best course of action for each patient. Find out more about how #FirstLook is improving cancer screening rates. https://lnkd.in/e5cDKPWa #DELFI #earlydetectionsaveslives #lungcancerscreening #everypatientisuniqu

Cancer Diagnoses Are Up, But So Are Survival Rates: The Importance of Early Detection A recent report highlights a crucial trend in cancer: while diagnoses are becoming more common, survival rates are also improving. Healthcare professionals stress the importance of early detection. Screening plays a vital role in identifying cancer at its most treatable stages. If you're at risk for lung cancer, consider getting screened if you are eligible. Here's why: Early detection significantly improves treatment outcomes Screening is quick, non-invasive, and could save your life Don't wait for symptoms to appear. Talk to your healthcare provider about your risk factors and whether lung cancer screening is right for you. Remember, knowledge is power. Stay informed, get screened, and take control of your health. #CancerAwareness #Lung https://n.pr/488xeVI

DELFI Diagnostics collaborated with leading experts to publish an article in the Journal of Clinical Medicine (JCM) MDPI on breakthroughs in cancer research that show promise in increasing #lungcancer screening uptake among eligible individuals who remain unscreened. The authors explore how liquid biopsies like the plasma whole genome fragmentome test by DELFI, can enhance screening participation and adherence. Discover how #FirstLookLung and DELFI are continuing to blaze a path forward for the future of cancer detection and improving patient outcomes. Read more: https://bit.ly/3Aup25k #FirstLookLungTest #RoutineScreening #LungHealth #earlydetectionsaveslives #sciencepubs #DELFI

The reality is that 15.1 million Americans are at an elevated risk for lung cancer and are eligible for screening, but most do not receive it. These individuals miss out on an opportunity to detect disease early before symptoms appear when treatments are most effective. So what can we do about it? 4 Things to know about the new #FirstLookLung Test:  • FirstLook Lung offers a convenient, personalized approach to enhance lung cancer screening, easily incorporated into routine blood work. • The test works to supplement lung cancer screening, such as a low-dose CT scan, but not replace it.  • FirstLook Lung does not diagnose lung cancer - instead, it analyzes blood to find DNA fragment patterns associated with lung cancer. • Personalized test results help doctors guide patients to make early, informed decisions about the best next steps. FirstLook Lung is offered by DELFI Diagnostics, who’s dedicated to enhancing the accessibility of lung cancer screening because #earlydetectionsaveslives To learn more, visit: https://lnkd.in/e5cDKPWa